191 related articles for article (PubMed ID: 12137568)
1. Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.
Arcenas R; Widen RH
BMC Microbiol; 2002 Jul; 2():20. PubMed ID: 12137568
[TBL] [Abstract][Full Text] [Related]
2. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
4. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
Evans TJ; Jacquemin MG; Farrell PJ
Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
[TBL] [Abstract][Full Text] [Related]
5. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
6. Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.
Mori T; Sairenji T
Virus Genes; 2006 Jun; 32(3):327-34. PubMed ID: 16732486
[TBL] [Abstract][Full Text] [Related]
7. Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV.
Cho MS; Fresen KO; zur Hausen H
Int J Cancer; 1980 Sep; 26(3):357-63. PubMed ID: 6270006
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
Leinbach SS; Summers WC
J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
[TBL] [Abstract][Full Text] [Related]
9. Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell Lymphoma.
Hatayama Y; Watanabe K; Ichikawa H; Kawamura K; Fukuda T; Motokura T
Viral Immunol; 2023 Oct; 36(8):520-525. PubMed ID: 37440168
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Epstein-Barr virus reactivation in a modeled spaceflight system.
Brinley AA; Theriot CA; Nelman-Gonzalez M; Crucian B; Stowe RP; Barrett AD; Pierson DL
J Cell Biochem; 2013 Mar; 114(3):616-24. PubMed ID: 22991253
[TBL] [Abstract][Full Text] [Related]
12. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
14. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
Takimoto T; Sato H; Ogura H
Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignancies.
Robertson KD; Barletta J; Samid D; Ambinder RF
Curr Top Microbiol Immunol; 1995; 194():145-54. PubMed ID: 7534666
[No Abstract] [Full Text] [Related]
17. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
18. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
Okano M; Aya T; Mizuno F; Takada K; Osato T
Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Epstein-Barr virus gene expression by other herpesviruses.
Kikuta H; Rapp F
Intervirology; 1988; 29(5):281-91. PubMed ID: 2848780
[TBL] [Abstract][Full Text] [Related]
20. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
D'Souza B; Rowe M; Walls D
J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
